158 related articles for article (PubMed ID: 29129025)
1. Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity.
Tacke C; Aleksandrova K; Rehfeldt M; Murahovschi V; Markova M; Kemper M; Hornemann S; Kaiser U; Honig C; Gerbracht C; Kabisch S; Hörbelt T; Ouwens DM; Weickert MO; Boeing H; Pfeiffer AFH; Pivovarova O; Rudovich N
J Cell Commun Signal; 2018 Sep; 12(3):539-548. PubMed ID: 29129025
[TBL] [Abstract][Full Text] [Related]
2. Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes.
Klimontov VV; Bulumbaeva DM; Fazullina ON; Lykov AP; Bgatova NP; Orlov NB; Konenkov VI; Pfeiffer AFH; Pivovarova-Ramich O; Rudovich N
J Cell Commun Signal; 2020 Mar; 14(1):101-109. PubMed ID: 31782053
[TBL] [Abstract][Full Text] [Related]
3. An Update to the WISP-1/CCN4 Role in Obesity, Insulin Resistance and Diabetes.
Mirr M; Owecki M
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33498604
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity.
Pivovarova-Ramich O; Loske J; Hornemann S; Markova M; Seebeck N; Rosenthal A; Klauschen F; Castro JP; Buschow R; Grune T; Lange V; Rudovich N; Ouwens DM
Cells; 2021 Apr; 10(5):. PubMed ID: 33946738
[TBL] [Abstract][Full Text] [Related]
5. Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: a randomized controlled trial.
Chang JS; Kim TH; Kong ID
Sci Rep; 2020 Jul; 10(1):10898. PubMed ID: 32616883
[TBL] [Abstract][Full Text] [Related]
6. The correlation between two potentially antagonistic human adipocytokines, WISP-1 and CTRP1, and their association with insulin resistance.
Mirr M; Braszak-Cymerman A; Ludziejewska A; Kręgielska-Narożna M; Bogdański P; Owecki M
Ann Agric Environ Med; 2023 Sep; 30(3):555-560. PubMed ID: 37772534
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease.
Karásková E; Kubickova V; Velganova-Veghova M; Geryk M; Foltenova H; Karasek D
Physiol Res; 2022 Apr; 71(2):275-284. PubMed ID: 35275697
[TBL] [Abstract][Full Text] [Related]
8. WISP1 is a novel adipokine linked to inflammation in obesity.
Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
[TBL] [Abstract][Full Text] [Related]
9. A functional analysis of Wnt inducible signalling pathway protein -1 (WISP-1/CCN4).
Stephens S; Palmer J; Konstantinova I; Pearce A; Jarai G; Day E
J Cell Commun Signal; 2015 Mar; 9(1):63-72. PubMed ID: 25657057
[TBL] [Abstract][Full Text] [Related]
10. CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function.
Yoshioka Y; Ono M; Maeda A; Kilts TM; Hara ES; Khattab H; Ueda J; Aoyama E; Oohashi T; Takigawa M; Young MF; Kuboki T
Bone; 2016 Feb; 83():162-170. PubMed ID: 26555637
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease.
Zhong X; Tu YJ; Li Y; Zhang P; Wang W; Chen SS; Li L; Chung AC; Lan HY; Chen HY; Li GS; Wang L
Am J Transl Res; 2017; 9(6):2920-2932. PubMed ID: 28670380
[TBL] [Abstract][Full Text] [Related]
12. Blockade of CCN4 attenuates CCl4-induced liver fibrosis.
Li X; Chen Y; Ye W; Tao X; Zhu J; Wu S; Lou L
Arch Med Sci; 2015 Jun; 11(3):647-53. PubMed ID: 26170860
[TBL] [Abstract][Full Text] [Related]
13. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
14. The role of CCN4/WISP-1 in the cancerous phenotype.
Nivison MP; Meier KE
Cancer Manag Res; 2018; 10():2893-2903. PubMed ID: 30214284
[TBL] [Abstract][Full Text] [Related]
15. Myonectin Predicts the Development of Type 2 Diabetes.
Li K; Liao X; Wang K; Mi Q; Zhang T; Jia Y; Xu X; Luo X; Zhang C; Liu H; Zhen H; Li L; Yang G
J Clin Endocrinol Metab; 2018 Jan; 103(1):139-147. PubMed ID: 29161407
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma.
Nagai Y; Watanabe M; Ishikawa S; Karashima R; Kurashige J; Iwagami S; Iwatsuki M; Baba Y; Imamura Y; Hayashi N; Baba H
Anticancer Res; 2011 Mar; 31(3):991-7. PubMed ID: 21498727
[TBL] [Abstract][Full Text] [Related]
17. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
18. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
19. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
[TBL] [Abstract][Full Text] [Related]
20. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
